MISSION & VISION

Our mission at AccuStem is to provide novel diagnostic tools that optimize outcomes and quality of life for all patients along the continuum of oncology care, from cancer screening through treatment and monitoring.

Our mission at AccuStem is to optimize outcomes for all patients with cancer across the globe.

We plan to drive innovation and cost savings in healthcare by offering a suite of novel molecular tools that enable more informed decision making for multi-disciplinary care teams.

Our Team

Our Team

Wendy Blosser AccuStem

Wendy Blosser
Chief Executive Officer

Jeff Fensterer AccuStem

Jeff Fensterer
Chief Operating Officer

Joe Flanagan AccuStem

Joe Flanagan
Chief Business Officer

Keeren Shah
Chief Finance Officer

Board of Directors

Board of Directors

Gabriele
Cerrone

Wendy
Blosser

John
Brancaccio

Willy
Simon

Our Story

AccuStem was founded in 2020 as a spinoff from Tiziana Life Sciences to commercialize a wide array of oncology products. While many organizations have focused on one of the three primary healthcare industry segments- pharmaceuticals, diagnostics or devices- our our ultimate goal is to offer novel solutions across all sectors.

Our lead product candidate focuses on the role of stem cells and tumor “stemness” in cancer biology, and we believe this concept will be applicable across a broad spectrum of tumor types. We will bring additional value to patients and their care team by offering ancillary testing that will provide a complementary and comprehensive suite of answers for treatment planning.

Our Story

AccuStem was founded in 2020 as a spinoff from Tiziana Life Sciences to commercialize a wide array of oncology products. While many organizations have focused on one of the three primary healthcare industry segments- pharmaceuticals, diagnostics or devices- our goal is to offer novel solutions across all sectors.

Our proprietary diagnostic focuses on the relationship between stem cells and cancer biology. We believe this “stemness” concept will be applicable across all tumor types. And we will bring additional value to patients and their care team by offering ancillary testing that will provide a complementary and comprehensive suite of answers for treatment planning.

Press Releases

Find out what media is saying about AccuStem

Read Latest Release

For More Information & Updates Contact Us Today

Thank you for your message. It has been sent.

There was an error trying to send your message. Please try again later.

“Our goal at AccuStem is to build best-in-class products for the treatment and management of all cancers.”

– Wendy Blosser, CEO

AccuStem CEO and CBO

“Our goal at AccuStem is to build best-in-class products for the treatment and management of all cancers”

– Wendy Blosser, CEO